Relay Therapeutics, Inc.
RLAY · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $15.4M | $10.0M | +53.4% |
| Operating income | −$303M | −$372M | +18.7% |
| Net income | −$276M | −$338M | +18.1% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $0K | $0K | |
| Operating income | −$90.2M | −$80.4M | −12.2% |
| Net income | −$81.7M | −$74.1M | −10.3% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Relay's revenue in FY2025?
- $15.4M in FY2025 (Fiscal year ended Dec 31, 2025), +53.4% vs $10.0M a year earlier, per its 10-K filed Feb 2026.
- Was Relay profitable in FY2025?
- No: net income was −$276M and operating income −$303M in FY2025.
- What was Relay's revenue in Q3 2026?
- $0K (n/a vs a year earlier), per its Form 10-Q filed Nov 4, 2026.